Similar Items: Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity
- Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters
- Comparative Efficacy and Safety of Tirzepatide in Asian and Non‐Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta‐Analysis
- Sarcopenia and sarcopenic obesity in type 2 diabetes mellitus and cardiovascular disease: current perspective and narrative review
- The Triglyceride‐Glucose Index Combined With Obesity Indices and Lower Extremity Artery Disease in Type 2 Diabetes: A Sex‐Stratified Analysis
- Adherence to UK Dietary Reference Values and Lower Odds of Non‐Alcoholic Fatty Liver Disease: A Secondary Analysis of a Case–Control Study
- Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials